Eduardo Ramos Elbal

Ramos Elbal E, Galera Miñarro AM, Llinares Riestra ME, Bermúdez Cortés M, Fuster Soler JL. Neuroblastoma: validation of the INRG classification system in a small series. Clin Transl Oncol. 2019 Dec;21(12):1776-1780. doi: 10.1007/s12094-019-02099-7. Epub 2019 Apr 4. PubMed PMID: 30949929.

AÑO: 2019; IF: 2.737

30949929

Fuster JL, Molinos-Quintana A, Fuentes C, Fernández JM, Velasco P, Pascual T, Rives S, Dapena JL, Sisinni L, López-Godino O, Palomo P, Villa-Alcázar M, Bautista F, González-Vicent M, López-Duarte M, García-Morín M, Ramos-Elbal E, Ramírez M; Leukemia Working Group of the Spanish Society of Pediatric Hematology, Oncology (SEHOP). Blinatumomab and inotuzumab for B cell precursor acute lymphoblastic leukaemia in children: a retrospective study from the Leukemia Working Group of the Spanish Society of Pediatric Hematology and Oncology (SEHOP). Br J Haematol. 2020 Sep;190(5):764-771. doi: 10.1111/bjh.16647. Epub 2020 Apr 21. PubMed PMID: 32314348.

AÑO: 2020; IF: 6.998

32314348

Martínez-Sánchez MV, Fuster JL, Campillo JA, Galera AM, Bermúdez-Cortés M, Llinares ME, Ramos-Elbal E, Pascual-Gázquez JF, Fita AM, Martínez-Banaclocha H, Galián JA, Gimeno L, Muro M, Minguela A. Expression of NK Cell Receptor Ligands on Leukemic Cells Is Associated with the Outcome of Childhood Acute Leukemia. Cancers (Basel). 2021 May 11;13(10). pii: 2294. doi: 10.3390/cancers13102294. PubMed PMID: 34064810; PubMed Central PMCID: PMC8151902.

AÑO: 2021; IF: 6.575

34064810

Ramos Elbal E, Fuster JL, Campillo JA, Galera AM, Cortes MB, Llinares ME, Jimenez I, Plaza M, Banaclocha HM, Galian JA, Blanquer Blanquer M, Martinez Sanchez MV, Muro M, Minguela A. Measurable residual disease study through three different methods can anticipate relapse and guide pre-emptive therapy in childhood acute myeloid leukemia. Clin Transl Oncol. 2023 Jan 4. doi: 10.1007/s12094-022-03042-z. Online ahead of print. PubMed PMID: 36598635.

AÑO: 2023; IF: 3.4

36598635

Ramos Elbal E, Fuster JL, Campillo JA, Galera AM, Cortes MB, Llinares ME, Jimenez I, Plaza M, Martinez Banaclocha H, Galian JA, Blanquer Blanquer M, Martinez Sanchez MV, Muro M, Minguela A. Measurable residual disease study through three different methods can anticipate relapse and guide early interventions in childhood acute lymphoblastic leukemia. Clin Transl Oncol. 2023 Jun 27. doi: 10.1007/s12094-023-03251-0. Online ahead of print. PubMed PMID: 37368200.

AÑO: 2023; IF: 3.4

37368200